ProfileGDS4718 / 213810_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 28% 27% 27% 29% 25% 36% 34% 20% 29% 22% 26% 33% 29% 45% 31% 24% 28% 25% 22% 32% 24% 22% 28% 25% 26% 29% 25% 31% 26% 31% 25% 40% 21% 25% 30% 31% 29% 25% 26% 29% 25% 29% 26% 30% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.447628
GSM549102patient 115, normal, homogenized [OPG study]4.4322627
GSM549104patient 119, normal, homogenized [OPG study]4.4039527
GSM549108patient 138, normal, homogenized [OPG study]4.5301529
GSM549119patient 077, normal, homogenized [OPG study]4.3513925
GSM549133patient 032, cancer, homogenized [OPG study]4.7492436
GSM549139patient 042, cancer, homogenized [OPG study]4.6909234
GSM549099patient 107, normal, homogenized [OPG study]4.1492920
GSM549109patient 139, normal, homogenized [OPG study]4.5217129
GSM549110patient 046, normal, homogenized [OPG study]4.212622
GSM549114patient 063, normal, homogenized [OPG study]4.3244826
GSM549122patient 082, normal, homogenized [OPG study]4.6633
GSM549134patient 033, cancer, homogenized [OPG study]4.4745529
GSM549136patient 036, cancer, homogenized [OPG study]5.1813545
GSM549140patient 044, cancer, homogenized [OPG study]4.5404831
GSM549111patient 047, normal, homogenized [OPG study]4.2717624
GSM549113patient 057, normal, homogenized [OPG study]4.4094128
GSM549132patient 031, cancer, homogenized [OPG study]4.3320725
GSM549137patient 038, cancer, homogenized [OPG study]4.2228822
GSM549142patient 047, cancer, homogenized [OPG study]4.7582632
GSM549100patient 110, normal, homogenized [OPG study]4.3172224
GSM549107patient 135, normal, homogenized [OPG study]4.1825722
GSM549115patient 068, normal, homogenized [OPG study]4.4059328
GSM549116patient 072, normal, homogenized [OPG study]4.3177725
GSM549120patient 078, normal, homogenized [OPG study]4.3614226
GSM549131patient 030, cancer, homogenized [OPG study]4.4606929
GSM549118patient 074, normal, homogenized [OPG study]4.3265525
GSM549129patient 027, cancer, homogenized [OPG study]4.5980531
GSM549123patient 088, normal, homogenized [OPG study]4.3618526
GSM549124patient 006, cancer, homogenized [OPG study]4.6071131
GSM549126patient 015, cancer, homogenized [OPG study]4.3331925
GSM549128patient 025, cancer, homogenized [OPG study]4.9686640
GSM549103patient 117, normal, homogenized [OPG study]4.2215521
GSM549117patient 073, normal, homogenized [OPG study]4.3252225
GSM549138patient 041, cancer, homogenized [OPG study]4.5052230
GSM549141patient 045, cancer, homogenized [OPG study]4.5045831
GSM549130patient 028, cancer, homogenized [OPG study]4.5108329
GSM549101patient 111, normal, homogenized [OPG study]4.3659725
GSM549105patient 128, normal, homogenized [OPG study]4.4039826
GSM549106patient 134, normal, homogenized [OPG study]4.4670929
GSM549112patient 048, normal, homogenized [OPG study]4.3173225
GSM549125patient 011, cancer, homogenized [OPG study]4.5149229
GSM549127patient 024, cancer, homogenized [OPG study]4.3531626
GSM549135patient 035, cancer, homogenized [OPG study]4.4830630